Cargando…
Managed Care Perspective on Three New Agents for Type 2 Diabetes
BACKGROUND: Despite effective monotherapy for diabetes, approximately 50% of patients require additional medications after 3 years to achieve target glycosylated hemoglobin (A1C) less than 7%. Three new agents, each the first in its therapeutic class with a unique mechanism of action, have been appr...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438140/ https://www.ncbi.nlm.nih.gov/pubmed/18500914 http://dx.doi.org/10.18553/jmcp.2008.14.4.363 |